Sign up to save your podcasts
Or
Share 056 | Merck’s new cholesterol pill, PlantForm goes to Brazil, and Mississauga shed its Pill Hill image
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
056 | Merck’s new cholesterol pill, PlantForm goes to Brazil, and Mississauga shed its Pill Hill image
In this episode of the Biotechnology Podcast, we report of the successful results of Merck’s anacetrapib trials. Dr. Don Stewart, principal of Canadian biotech firm PlantForm discusses why his company is building a laboratory in Brazil. We also take a look at Mississauga’s new life science strategy.
View all episodes
By Biotechnology FocusIn this episode of the Biotechnology Podcast, we report of the successful results of Merck’s anacetrapib trials. Dr. Don Stewart, principal of Canadian biotech firm PlantForm discusses why his company is building a laboratory in Brazil. We also take a look at Mississauga’s new life science strategy.